Andrew Dunford has been a member of the Getz Lab since October 2013. In his tenure he has worked on multiple cancer types, including lymphoma and myeloma, as well as contributed to novel methods for identifying somatic mutations in the absence of paired normals, as well as worked on project spanning cancer types, such as by identifying genes on chromosome X that contribute to elevated risk of cancer in men. Starting in January 2022, Andrew has begun studying as an environmental engineer in the hopes of curing cancer at the source by applying the quantitative outlook he’s learned in the lab to creating an environment without toxicants.
-
Dutta AK, Alberge JB, [...], Getz G, Ghobrial IM
Cancer Discovery
(2022).
-
Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, [...], Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G
Nature Genetics
(2022).
-
Bustoros M, Anand S, [...], Getz G, Ghobrial IM
Nature Communications
(2022).
-
Beauchamp EM, [...], Jaiswal S, Ebert BL
Blood Cancer Discovery
2
(5)
500-517
(2021).
-
Busteros M, Sklavenitis-Pistofidis R, [...], Manier S, Getz G, Ghobrial IM
Journal of Clinical Oncology
38
(21)
2380-2389
(2020).
-
Chapuy B, Stewart C, Dunford AJ, [...], Getz G, Shipp MA
Blood
134
(26)
2369-2382
(2019).
-
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, [...], Fromm JR, Getz G, Shipp MA
Blood Advances
3
(23)
4065-4080
(2019).
-
Chapuy B, Stewart C, Dunford AJ, [...], Getz G, Shipp MA
Nature Medicine
24
(5)
679-690
(2018).
-
Dunford A, Weinstock D, [...], Lawrence MS, Getz G, Lane AA
Nature Genetics
49
(1)
10-16
(2016).